RMM, Contamination Control, Sterility Assurance and EM to be discussed at Microbiology East Coast

SMi Group reports: Key pressing questions on rapid microbial methods, contamination control, sterility assurance and environmental monitoring will be addressed at the Microbiology East Coast Conference in Boston this April 2022.
By: SMi Group
 
BOSTON - March 8, 2022 - PRLog -- Microbiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals, to detect and eliminate microorganisms that would pose a risk to patients and jeopardise product batches.

SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference will review implementation guidance and validation for efficient disinfectant efficacy programs and uncover principles in best-practice and the benefits of a robust contamination control strategy. The conference is taking place on 27th to 28th April 202 in Boston, MA, USA.

Interested parties can interested parties can secure their attendance via: http://www.microbiologyeastcoast.com/PR3

SMi Group has released key conference sessions and questions that will be answered by key influential and inspiring experts in the pharmaceutical microbiology field over the two-day conference, the sessions include:

Day One - OPENING ADDRESS on Designing an Efficient Disinfectant Efficacy Program
Hilary Chan, Principal QC Scientist, Takeda
Stephen Yang, Director – Global Sterile & Validation COE, Merck & Co.

Day One - COVID SPOTLIGHT on Impacts of the SARS-CoV-2 pandemic on the biopharmaceutical industry
Lynne Ensor, Vice President, Regulatory Consulting Services Head of Global Compliance, Parexel International, Inc.

Day One - FDA SPOTLIGHT SESSION on Common Issues in The Sterility Assurance Assessment
John Arigo, Director, Division of Microbiology Assessment, Office of Pharmaceutical Manufacturing Assessment, FDA

Day Two OPENING ADDRESS on a Case Study: Expediting Mold Contamination Investigations with the Use of Biofluorescent Particle Counting Technology
Dawn Watson, Director – Microbial Control, Sterile & Validation Center of Excellence, MSD

Day Two - KEYNOTE SESSION on Microbial control: Risk assessment of traditional culture-based microbiological tests requiring contemporaneous verification
Lena Hoch, Microbiologist Specialist, Quality Control Microbiology - Projects, GSK

Day Two - MICROBIOTA SPOTLIGHT SESSION on Contamination Control as it relates to Microbiome Drug Product manufacture - Misconceptions and grey areas in non-sterile product manufacturing
Sean O'Brien, Director, Quality Control External Operations, Seres Therapeutics

To view the full the agenda, download the conference brochure, please visit: http://www.microbiologyeastcoast.com/PR3

Sponsored by: Associates of Cape Cod, Bioscience International, Ecolab, Mettler Toledo and Microbiologics

For tailored sponsorship and branding packages contact Daniele Moreschi, Sales Director on +44(0)20 7827 6050 or email  dmoreschi@smi-online.co.uk

For media enquiries or a press pass contact Simi Sapal, Head of Marketing on +44 (0) 20 7827 6162 or email ssapal@smi-online.co.uk

SMi's 5th Pharmaceutical Microbiology East Coast Conference
April 27-28, 2022
Boston, MA, USA
#SMiPharmaMicroEC
http://www.microbiologyeastcoast.com/PR3

Contact
SMi Group
Simi Sapal
***@smi-online.co.uk
End
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Pharmaceutical Microbiology
Industry:Medical
Location:Boston - Massachusetts - United States
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share